In the BioHarmony Drug Report Database

"Preview" Icon

Aminoglutethimide

Cytadren (aminoglutethimide) is a small molecule pharmaceutical. Aminoglutethimide was first approved as Cytadren on 1982-01-01. It is used to treat breast neoplasms, cushing syndrome, hormone-dependent neoplasms, and prostatic neoplasms in the USA. It is known to target aromatase and cholesterol side-chain cleavage enzyme, mitochondrial.

 

Trade Name

 

Cytadren
 

Common Name

 

aminoglutethimide
 

ChEMBL ID

 

CHEMBL488
 

Indication

 

breast neoplasms, cushing syndrome, hormone-dependent neoplasms, prostatic neoplasms
 

Drug Class

 

Aromatase inhibitor; Antiestrogen; Steroidogenesis inhibitor; Antiglucocorticoid

Image (chem structure or protein)

Aminoglutethimide structure rendering